The common saying goes "The third time's a charm" but for Nima Farzan, he's looking to go 3-for-3 successfully running biotechnology companies. On July 22, Farzan was appointed to be Latigo Biotherapeutics, a clinical-stage biotech company based in Thousand Oaks, first CEO. Farzan's experience spans more than two decades long in the biopharmaceutical industry, including being the…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
